SOPHiA GENETICS

SOPHiA GENETICS (Nasdaq: SOPH) is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It is the creator of the SOPHiA DDM™ Platform, a cloud-based SaaS platform capable of analyzing data and generating

SOPHiA GENETICS has been operating since 2011. You can verify their legitimacy through their official website and social media presence.

SOPHiA GENETICS operates in the analytics sector of the cryptocurrency industry. Compare SOPHiA GENETICS with other analytics companies on Crypto News Navigator to evaluate services, features, and reputation before making your decision.

Before using SOPHiA GENETICS, research their track record (operating since 2011), verify their regulatory compliance, read user reviews, and understand their fee structure. Never share your private keys with any service, and start with small amounts until you are comfortable with the platform.

Safety depends on multiple factors including regulatory compliance, security practices, and track record. SOPHiA GENETICS is based in Boston, Massachusetts, USA, has been operating since 2011. Always enable two-factor authentication, use strong passwords, and never store large amounts on any third-party platform.

SOPHiA GENETICS is located in Boston, Massachusetts, USA, in the North America region. They serve customers in Global.

SOPHiA GENETICS was founded in 2011. The company currently has 450 employees.